10x Genomics (TXG) Change in Inventory (2018 - 2026)

10x Genomics has disclosed Change in Inventory across 9 years of filings, most recently posting -$3.0 million for Q2 2026.

• In Q2 2026, Change in Inventory rose 57.29% year-over-year to -$3.0 million; the TTM figure through Jun 2026 stood at -$18.6 million (up 9.14% YoY), while the FY2025 annual figure was -$28.0 million, down 385.91% from the prior year.
• Change in Inventory came in at -$3.0 million for Q2 2026 at 10x Genomics, down from -$2.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $9.9 million in Q1 2024 to a low of -$9.6 million in Q4 2024.
• Average Change in Inventory over 5 years is -$586555.6, with a median of -$1.1 million recorded in 2023.
• Year-over-year, Change in Inventory plunged 632.08% in 2023 and soared 2113.14% in 2024.
• Over 5 years, Change in Inventory stood at $1.4 million in 2022, then sank by 632.08% to -$7.6 million in 2023, then dropped by 26.33% to -$9.6 million in 2024, then jumped by 41.97% to -$5.6 million in 2025, then jumped by 46.24% to -$3.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were -$3.0 million in Q2 2026, -$2.7 million in Q1 2026, and -$5.6 million in Q4 2025.